- Home
- ILAG vs ACXP Comparison
ILAG vs ACXP Comparison
Compare ILAG & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILAG
- ACXP
- Stock Information
- Founded
- ILAG 1981
- ACXP 2017
- Country
- ILAG Hong Kong
- ACXP United States
- Employees
- ILAG N/A
- ACXP N/A
- Industry
- ILAG Office Equipment/Supplies/Services
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- ILAG Consumer Discretionary
- ACXP Health Care
- Exchange
- ILAG Nasdaq
- ACXP Nasdaq
- Market Cap
- ILAG 9.4M
- ACXP 8.4M
- IPO Year
- ILAG 2022
- ACXP 2021
- Fundamental
- Price
- ILAG $0.51
- ACXP $0.47
- Analyst Decision
- ILAG
- ACXP Strong Buy
- Analyst Count
- ILAG 0
- ACXP 2
- Target Price
- ILAG N/A
- ACXP $10.00
- AVG Volume (30 Days)
- ILAG 427.2K
- ACXP 18.7M
- Earning Date
- ILAG 07-22-2025
- ACXP 08-08-2025
- Dividend Yield
- ILAG N/A
- ACXP N/A
- EPS Growth
- ILAG N/A
- ACXP N/A
- EPS
- ILAG N/A
- ACXP N/A
- Revenue
- ILAG $7,506,551.00
- ACXP N/A
- Revenue This Year
- ILAG N/A
- ACXP N/A
- Revenue Next Year
- ILAG N/A
- ACXP N/A
- P/E Ratio
- ILAG N/A
- ACXP N/A
- Revenue Growth
- ILAG 16.50
- ACXP N/A
- 52 Week Low
- ILAG $0.34
- ACXP $0.30
- 52 Week High
- ILAG $1.35
- ACXP $3.33
- Technical
- Relative Strength Index (RSI)
- ILAG 51.90
- ACXP 52.38
- Support Level
- ILAG $0.49
- ACXP $0.45
- Resistance Level
- ILAG $0.52
- ACXP $0.59
- Average True Range (ATR)
- ILAG 0.05
- ACXP 0.08
- MACD
- ILAG -0.01
- ACXP -0.01
- Stochastic Oscillator
- ILAG 41.32
- ACXP 27.06
About ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.